Trial Details
COMPLETEDBasic Information
| Clinical ID | c3305 |
|---|---|
| Identifier | NCT02251483 |
| Trial Title | Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Diarrhea Predominant Irritable Bowel Syndrome|Small Intestinal Bacterial Overgrowth |
| Interventions | OTHER: Serum-derived bovine immunoglobulin protein isolate (SBI)|OTHER: Placebo |
Participant Information
| Sponsor | Cedars-Sinai Medical Center |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2014-09 |
|---|---|
| Primary Completion Date | 2015-07 |
| Completion Date | 2015-07 |